-Press Information Bureau (Ministry of Health and Family Welfare) Healthcare for all, particularly for the rural areas has been a priority for the Government. The health indicators like Infant Mortality Rate (IMR), Total Fertility Rate (TFR), and nutritional status of children under 3 years including prevalence of anemia amongst them and pregnant women in rural area are considerably poor as compared to urban areas. The key health indicators are as under: Public...
More »SEARCH RESULT
Pills for polls-Kundan Pandey
-Down to Earth The free medicine scheme in Rajasthan may benefit Congress Of the many poll sops that Rajasthan Chief Minister Ashok Gehlot doled out in the past two years, the one scheme that seems to have struck the right chord with voters is the initiative to give free essential medicines at government healthcare facilities. The Mukhyamantri Nishulk Dava Yojna, launched in 2011, has offered some hope to the incumbent Congress government,...
More »80% of medicines not covered by price control order -Rema Nagarajan
-The Times of India About 38 million people in India (which is more than Canada's population) fall below the poverty line every year due to healthcare expenses, of which 70% is on purchase of drugs. Yet, the much-awaited drug price control order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in the market. Many drugs crucial for India's disease profile have been...
More »Branded medicines cost 15 times more than generic ones
-The Times of India NEW DELHI: Branded medicines cost 2-15 times more than non-branded generic medicines sold at Jan Aushadhi stores. For example, a 10-tablet strip of Diclofenac SR (100mg), a popular pain killer, costs Rs 51.91 whereas the same generic medicine costs only Rs 3.35 at Jan Aushadhi stores. An 100 ml bottle of cough syrup manufactured and marketed by drug companies costs Rs 33 while those sold at Jan Aushadhi...
More »Drug price policy under SC glare
-The Telegraph New Delhi: The Supreme Court today ticked off the government for "dilly dallying" on an affordable drug pricing policy, following a petition that said the delay was aimed at pushing through suggestions of the powerful manufacturers' lobby. A bench of Justices G.S. Singhvi and Gopala Gowda asked the Centre to respond within six weeks. The All India Drug Action Network (AIDAN) had filed the application saying the government was delaying a...
More »